Developing vaccines for infectious diseases and biodefense
Development of Therapeutic Candidates for Biodefense, Infections and Emerging Infectious Diseases
['FUNDING_OTHER'] · ACCESS TO ADVANCED HEALTH INSTITUTE · NIH-11127346
This study is working on developing new vaccines to protect people from infectious diseases that could come from natural outbreaks or intentional releases, and it's testing these vaccines in animals to make sure they're safe and effective before they can be used in humans.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ACCESS TO ADVANCED HEALTH INSTITUTE (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11127346 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing vaccines for infectious diseases that may arise from natural outbreaks or intentional releases. It involves formulating vaccine components and conducting various tests in animal models to ensure their safety and effectiveness. The research aims to advance these candidates through the necessary regulatory processes to eventually evaluate their safety and efficacy in humans. Patients may benefit from the development of new vaccines that could protect against emerging infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit are individuals at risk of exposure to emerging infectious diseases or those in need of new vaccine options.
Not a fit: Patients who are not at risk for infectious diseases or who have existing effective vaccines may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases using similar approaches, indicating a promising path forward.
Where this research is happening
SEATTLE, UNITED STATES
- ACCESS TO ADVANCED HEALTH INSTITUTE — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VOIGT, EMILY — ACCESS TO ADVANCED HEALTH INSTITUTE
- Study coordinator: VOIGT, EMILY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Disease Outbreaks, Emerging Communicable Diseases, Emerging Infectious Diseases, Infectious Disease Pathway